Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.4K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.4K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

77
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
77
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

144
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
144
Human Genetics01:28

Human Genetics

1.9K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
What is Genetic Engineering?00:49

What is Genetic Engineering?

81.3K
Overview
81.3K
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

1.8K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants.

Public health genomics·2011
Same author

Replication of genome-wide association studies (GWAS) loci for fasting plasma glucose in African-Americans.

Diabetologia·2010
Same author

Replication-related activities establish cohesion between sister chromatids.

Cell biochemistry and biophysics·2002
Same author

Eukaryotic DNA polymerases: proposal for a revised nomenclature.

The Journal of biological chemistry·2001
Same author

Separase anxiety: dissolving the sister bond and more.

Nature cell biology·2001
Same author

Evidence that replication fork components catalyze establishment of cohesion between sister chromatids.

Proceedings of the National Academy of Sciences of the United States of America·2001

Related Experiment Video

Updated: Mar 31, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K

Direct-to-consumer genetic testing: Perspectives on its value in healthcare.

S K Delaney1, M F Christman1

  • 1Coriell Institute for Medical Research, Camden, New Jersey, USA.

Clinical Pharmacology and Therapeutics
|October 31, 2015
PubMed
Summary

Direct-to-consumer genetic testing faced regulatory challenges, prompting a reevaluation of its role. We examine lessons learned and future directions for personalized genetic services.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K

Related Experiment Videos

Last Updated: Mar 31, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K

Area of Science:

  • Genetics
  • Bioethics
  • Regulatory Science

Background:

  • The direct-to-consumer (DTC) genetic testing industry faced significant regulatory scrutiny, notably the US Food and Drug Administration's (FDA) 2013 order for 23andMe to cease marketing its Personal Genome Service.
  • This event marked a critical juncture in the debate surrounding the accessibility, accuracy, and ethical implications of DTC genetic information.
  • Following this, 23andMe re-emerged in 2015 with FDA approval for a specific carrier test, signaling a shift towards a more regulated market.

Purpose of the Study:

  • To analyze the impact of the FDA's regulatory actions on the DTC genetic testing landscape.
  • To synthesize the key learnings from the period of intense debate and regulatory intervention.
  • To propose future directions for DTC genetic testing, considering scientific advancements and consumer protection.

Main Methods:

  • Review of regulatory actions and industry responses.
  • Analysis of scientific literature and ethical discussions concerning DTC genetic testing.
  • Examination of market trends and consumer engagement with genetic information.

Main Results:

  • The FDA's intervention led to a more cautious and regulated approach by DTC genetic testing companies.
  • Consumer understanding and expectations of genetic information have evolved, highlighting the need for clear communication and genetic counseling.
  • The industry is moving towards offering more clinically relevant and validated genetic tests.

Conclusions:

  • The regulatory landscape has shaped the DTC genetic testing market, emphasizing the importance of scientific validity and consumer safety.
  • Future growth depends on balancing innovation with robust regulatory oversight and ethical considerations.
  • Integrating genetic testing into healthcare requires addressing data privacy, genetic literacy, and equitable access.